Source: International Congress 2019 – Clinical aspects of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Oishi (Ube, Japan), T. Hirano (Ube, Japan), K. Matsuda (Ube, Japan), K. Hamada (Ube, Japan), S. Uehara (Ube, Japan), R. Suetake (Ube, Japan), Y. Yamaji (Ube, Japan), M. Asami-Noyama (Ube, Japan), N. Edakuni (Ube, Japan), K. Matsunaga (Ube, Japan). The prevalence and clinical characteristics of T2-high and T2-low endotype of severe uncontrolled asthma distinguished by combining popular type-2 biomarkers. 2749

Member's Comments

No comment yet.

Related content which might interest you: The prevalence of subtypes of type-2 inflammation in a real-life population of patients with difficult-to-control asthma Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021 Year: 2021 The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Source: Eur Respir J 2003; 22: 470-477 Year: 2003 BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 The subclinical atherosclerosis and its association to clinical features of stable COPD Source: Annual Congress 2011 - COPD management Year: 2011 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Clinical characteristics of severe asthma subphenotypes Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Baseline characteristics of severe asthma patients initiating biologic treatment worldwide Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Age-of-asthma onset and epidemiological characteristics of late-onset asthma in a general population Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018 Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Comparison of clinical characteristics between stable COPD patients with- and without mild bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 257s Year: 2002 Relationship between longitudinal changes in type-2 inflammation and clinical outcomes in young asthmatics Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Defining the clinical clusters of severe asthma within UBIOPRED Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 Features of differences in clinical anamnestic, functional indicators, and alpha-1-antitripsin, in teenagers with chronic bronchitis, in the gender-age aspect Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Component-resolved allergy diagnostics identify phenotypes in problematic severe childhood asthma Source: Annual Congress 2011 - Risk and detection of childhood asthma and allergy Year: 2011 Clinical characteristics of adult obese asthma with type-2 inflammation dominant Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Prevalence and clinical relevance of comorbidities in IPF Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018